Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands

Objectives: Omicron appears to lead to a milder illness for patients compared with previous COVID-19 variants. However, not all infected with Omicron would describe their illness as mild. In this study, we investigate the experienced severity and symptoms of the Omicron variant. Methods: We conducte...

Full description

Bibliographic Details
Published in:International Journal of Infectious Diseases
Main Authors: Maria Skaalum Petersen, Sunnvør í Kongsstovu, Eina H. Eliasen, Sólrun Larsen, Jóhanna Ljósá Hansen, Nicolina Vest, Maria Marjunardóttir Dahl, Debes Hammershaimb Christiansen, Lars Fodgaard Møller, Marnar Fríðheim Kristiansen
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier 2022
Subjects:
Online Access:https://doi.org/10.1016/j.ijid.2022.07.005
https://doaj.org/article/15b522da704a451d98a5198da7bb2dc5
id ftdoajarticles:oai:doaj.org/article:15b522da704a451d98a5198da7bb2dc5
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:15b522da704a451d98a5198da7bb2dc5 2023-05-15T16:10:42+02:00 Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands Maria Skaalum Petersen Sunnvør í Kongsstovu Eina H. Eliasen Sólrun Larsen Jóhanna Ljósá Hansen Nicolina Vest Maria Marjunardóttir Dahl Debes Hammershaimb Christiansen Lars Fodgaard Møller Marnar Fríðheim Kristiansen 2022-09-01T00:00:00Z https://doi.org/10.1016/j.ijid.2022.07.005 https://doaj.org/article/15b522da704a451d98a5198da7bb2dc5 EN eng Elsevier http://www.sciencedirect.com/science/article/pii/S1201971222004052 https://doaj.org/toc/1201-9712 1201-9712 doi:10.1016/j.ijid.2022.07.005 https://doaj.org/article/15b522da704a451d98a5198da7bb2dc5 International Journal of Infectious Diseases, Vol 122, Iss , Pp 636-643 (2022) Omicron COVID-19 Clinical characteristics Faroe Islands Survey Infectious and parasitic diseases RC109-216 article 2022 ftdoajarticles https://doi.org/10.1016/j.ijid.2022.07.005 2022-12-30T20:02:44Z Objectives: Omicron appears to lead to a milder illness for patients compared with previous COVID-19 variants. However, not all infected with Omicron would describe their illness as mild. In this study, we investigate the experienced severity and symptoms of the Omicron variant. Methods: We conducted a nationwide cross-sectional study, including 5036 individuals of all ages, consisting of reverse transcription-polymerase chain reaction confirmed SARS-CoV-2 cases from 1 January to 31 January 2022 (n = 4506) and a control group without SARS-COV-2 infection in December 2021 or January 2022 (n = 530). Omicron was dominant during this period. Cases were asked about their acute symptoms and answered a web-based questionnaire 10–30 days after their positive test while controls were asked about symptoms during the past week. Results: Among cases, 97% reported at least one symptom during the acute phase compared with 79% of controls. Just over half the cases assessed their illness as asymptomatic or mild, whereas 46% assessed their illness as moderate or severe. Children reported fewer symptoms and less severe illnesses than adults (P <0.001). The largest risk differences (RDs) between adult cases and controls due to symptoms were observed for fever (RD = 60.6%, confidence interval [CI] 57.4–63.6), fatigue (RD = 49.6%, CI 44.1–54.7), and chills (RD = 48.8%, CI 43.8–53.2). Conclusion: Most of those infected with Omicron experience symptoms, and the Omicron variant appears to lead to less severe disease. However, this does not mean that all the infected experience an Omicron infection as mild. The unprecedented rate of Omicron infections worldwide leads to urgent questions about the rate of long COVID after Omicron infections. Article in Journal/Newspaper Faroe Islands Directory of Open Access Journals: DOAJ Articles Faroe Islands International Journal of Infectious Diseases 122 636 643
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Omicron
COVID-19
Clinical characteristics
Faroe Islands
Survey
Infectious and parasitic diseases
RC109-216
spellingShingle Omicron
COVID-19
Clinical characteristics
Faroe Islands
Survey
Infectious and parasitic diseases
RC109-216
Maria Skaalum Petersen
Sunnvør í Kongsstovu
Eina H. Eliasen
Sólrun Larsen
Jóhanna Ljósá Hansen
Nicolina Vest
Maria Marjunardóttir Dahl
Debes Hammershaimb Christiansen
Lars Fodgaard Møller
Marnar Fríðheim Kristiansen
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
topic_facet Omicron
COVID-19
Clinical characteristics
Faroe Islands
Survey
Infectious and parasitic diseases
RC109-216
description Objectives: Omicron appears to lead to a milder illness for patients compared with previous COVID-19 variants. However, not all infected with Omicron would describe their illness as mild. In this study, we investigate the experienced severity and symptoms of the Omicron variant. Methods: We conducted a nationwide cross-sectional study, including 5036 individuals of all ages, consisting of reverse transcription-polymerase chain reaction confirmed SARS-CoV-2 cases from 1 January to 31 January 2022 (n = 4506) and a control group without SARS-COV-2 infection in December 2021 or January 2022 (n = 530). Omicron was dominant during this period. Cases were asked about their acute symptoms and answered a web-based questionnaire 10–30 days after their positive test while controls were asked about symptoms during the past week. Results: Among cases, 97% reported at least one symptom during the acute phase compared with 79% of controls. Just over half the cases assessed their illness as asymptomatic or mild, whereas 46% assessed their illness as moderate or severe. Children reported fewer symptoms and less severe illnesses than adults (P <0.001). The largest risk differences (RDs) between adult cases and controls due to symptoms were observed for fever (RD = 60.6%, confidence interval [CI] 57.4–63.6), fatigue (RD = 49.6%, CI 44.1–54.7), and chills (RD = 48.8%, CI 43.8–53.2). Conclusion: Most of those infected with Omicron experience symptoms, and the Omicron variant appears to lead to less severe disease. However, this does not mean that all the infected experience an Omicron infection as mild. The unprecedented rate of Omicron infections worldwide leads to urgent questions about the rate of long COVID after Omicron infections.
format Article in Journal/Newspaper
author Maria Skaalum Petersen
Sunnvør í Kongsstovu
Eina H. Eliasen
Sólrun Larsen
Jóhanna Ljósá Hansen
Nicolina Vest
Maria Marjunardóttir Dahl
Debes Hammershaimb Christiansen
Lars Fodgaard Møller
Marnar Fríðheim Kristiansen
author_facet Maria Skaalum Petersen
Sunnvør í Kongsstovu
Eina H. Eliasen
Sólrun Larsen
Jóhanna Ljósá Hansen
Nicolina Vest
Maria Marjunardóttir Dahl
Debes Hammershaimb Christiansen
Lars Fodgaard Møller
Marnar Fríðheim Kristiansen
author_sort Maria Skaalum Petersen
title Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
title_short Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
title_full Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
title_fullStr Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
title_full_unstemmed Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
title_sort clinical characteristics of the omicron variant - results from a nationwide symptoms survey in the faroe islands
publisher Elsevier
publishDate 2022
url https://doi.org/10.1016/j.ijid.2022.07.005
https://doaj.org/article/15b522da704a451d98a5198da7bb2dc5
geographic Faroe Islands
geographic_facet Faroe Islands
genre Faroe Islands
genre_facet Faroe Islands
op_source International Journal of Infectious Diseases, Vol 122, Iss , Pp 636-643 (2022)
op_relation http://www.sciencedirect.com/science/article/pii/S1201971222004052
https://doaj.org/toc/1201-9712
1201-9712
doi:10.1016/j.ijid.2022.07.005
https://doaj.org/article/15b522da704a451d98a5198da7bb2dc5
op_doi https://doi.org/10.1016/j.ijid.2022.07.005
container_title International Journal of Infectious Diseases
container_volume 122
container_start_page 636
op_container_end_page 643
_version_ 1765995855445229568